Merit Medical Systems 第一季度收益预期超出预期，更新了 2025 财年指引，股价跌至 102.05 美元。 Merit Medical Systems beats Q1 earnings estimates, updates FY 2025 guidance, shares dip to $102.05.

特效医疗系统(MMSI)报告,每股0.93美元的 " Q1 " 收入比预期的要强,每股0.93美元,比预期的高出0.11美元。 Merit Medical Systems (MMSI) reported a stronger-than-expected Q1 earnings of $0.93 per share, beating estimates by $0.11. 该公司将2025财政年度EPS指南更新为3.580-3.700,股票交易额降至102.05美元。 The company updated its FY 2025 EPS guidance to 3.580-3.700, with shares trading down to $102.05. MMSI的市场上限是59.5亿美元,P/E比率是50.02。 MMSI has a market cap of $5.95 billion and a P/E ratio of 50.02. 分析师有“机动购买”评级,目标价格为109.80美元。 Analysts have a "Moderate Buy" rating with a $109.80 target price. 该公司提供用于诊断和治疗程序的医疗产品。 The company provides medical products for diagnostic and therapeutic procedures.